BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35937409)

  • 21. Long non-coding RNA long intergenic non-protein coding RNA 1232 promotes cell proliferation, migration and invasion in bladder cancer via modulating miR-370-5p/PIM3 axis.
    Feng F; Yang J; Chen A; Cui M; Li L
    J Tissue Eng Regen Med; 2022 Jun; 16(6):575-585. PubMed ID: 35338769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis.
    Wang J; Liu Y; Cai H; Jiang H; Li W; Shi Y
    Bioengineered; 2021 Dec; 12(1):6264-6274. PubMed ID: 34499007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA MIR205HG function as a ceRNA to accelerate tumor growth and progression via sponging miR-122-5p in cervical cancer.
    Li Y; Wang H; Huang H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):78-85. PubMed ID: 31023531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p.
    Jiang H; Huang G; Zhao N; Zhang T; Jiang M; He Y; Zhou X; Jiang X
    J Exp Clin Cancer Res; 2018 Jul; 37(1):169. PubMed ID: 30045766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA AL592284.1 facilitates proliferation and metastasis of cervical cancer cells via miR-30a-5p/Vimentin/EMT axis.
    Zhang J; Liu HL; Liu JB; Zhang Y; Liu J; Li YH
    Biochem Biophys Res Commun; 2021 Nov; 577():95-102. PubMed ID: 34509725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced long non-coding RNA PTENP1 contributed to proliferation and invasion via miR-19b/MTUS1 axis in patients with cervical cancer.
    Ou L; Xiang TY; Hao XY; Wang DZ; Zeng Q
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4132-4144. PubMed ID: 32373949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA TDRG1 promotes hypoxia-induced glycolysis by targeting the miR-214-5p/SEMA4C axis in cervical cancer cells.
    Li X; Zhang C; Tian Y
    J Mol Histol; 2021 Apr; 52(2):245-256. PubMed ID: 33394293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of lncRNA LINC00707 alleviates LPS-induced injury in MRC-5 cells by acting as a ceRNA of miR-223-5p.
    Zou X; Gao C; Shang R; Chen H; Wang B
    Biosci Biotechnol Biochem; 2021 Feb; 85(2):315-323. PubMed ID: 33604647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HNRNPU-AS1 Regulates Cell Proliferation and Apoptosis via the MicroRNA 205-5p/AXIN2 Axis and Wnt/β-Catenin Signaling Pathway in Cervical Cancer.
    Niu Z; Wang F; Lv S; Lv Y; Liu M; Fu L; Yao Y; Wang L; Lin W; Yuan F
    Mol Cell Biol; 2021 Sep; 41(10):e0011521. PubMed ID: 34309414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
    Dai SG; Guo LL; Xia X; Pan Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):486-495. PubMed ID: 30720155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA LINC00707 serves as a sponge of miR-382-5p to alleviate lipopolysaccharide (LPS)-induced WI-38 cell injury through upregulating NKAP in infantile pneumonia.
    Chen L; Chen Y; Huang J; Zhang J
    Autoimmunity; 2022 Aug; 55(5):328-338. PubMed ID: 35593504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2.
    Yan K; Hu C; Liu C; Chu G; Wang X; Ma S; Li L
    Histol Histopathol; 2023 Jul; 38(7):823-835. PubMed ID: 36444938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINC00511 promotes cervical cancer progression by regulating the miR-497-5p/MAPK1 axis.
    Lu M; Gao Q; Wang Y; Ren J; Zhang T
    Apoptosis; 2022 Dec; 27(11-12):800-811. PubMed ID: 36103025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA hsa_circ_0011385 contributes to cervical cancer progression through sequestering miR-149-5p and increasing PRDX6 expression.
    Hu L; Zhou M; Xue L; Zhang J
    Reprod Biol; 2022 Jun; 22(2):100619. PubMed ID: 35240453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long intergenic noncoding RNA LINC01287 drives the progression of cervical cancer via regulating miR-513a-5p/SERP1.
    Hu Y; Zhang W; Liu Z; Xing Q; Liu R; Yan Q; Li W; Liu X
    Hum Cell; 2022 Sep; 35(5):1577-1590. PubMed ID: 35895184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00958 facilitates cervical cancer cell proliferation and metastasis by sponging miR-625-5p to upregulate LRRC8E expression.
    Wang L; Zhong Y; Yang B; Zhu Y; Zhu X; Xia Z; Xu J; Xu L
    J Cell Biochem; 2020 Mar; 121(3):2500-2509. PubMed ID: 31691355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer.
    Kapora E; Feng S; Liu W; Sakhautdinova I; Gao B; Tan W
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31266812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA LINC00707 acts as a competing endogenous RNA to enhance cell proliferation in colorectal cancer.
    Wang H; Luan H; Zhan T; Liu X; Song J; Dai H
    Exp Ther Med; 2020 Feb; 19(2):1439-1447. PubMed ID: 32010320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2.
    Wu EY; Huang LP; Bao JH
    Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.